Medtronic dips on miss and lower guidance from slow procedure and supply recovery
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Medtronic reports second quarter fiscal 2023 financial results
November 22, 2022 6:45 AM ESTEarnings delivered despite slower market procedure volume and supply recovery; Growth driven by TAVR, Pacing, U.S. Core Spine, and International Diabetes
DUBLIN, Nov. 22, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2023, which ended October 28, 2022.
Key Highlights
Revenue of $7.6 billion decreased 3% as reported and increased 2% organicGAAP diluted EPS of $0.32 decreased 67%; non-GAAP diluted EPS of $1.30 decreased 2%Company updates guidance; expects... More